
Remdesivir approved by the FDA
Remdesivir has finally received FDA approval from the US Food and Drug Administration.
Generic Name: Gadodiamide
Pharmacologic Category: Radiological/Contrast Media (Nonionic, Low Osmolality)
Dosage Form and Strengths: 287 mg/mL (10 mL) solution in a vial for injection
Indications: Roniscan is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity within the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space (Body imaging) and also lesions with abnormal vascularity in the brain, spine, and associated tissues (CNS imaging).
Generic Name: Gadodiamide
Pharmacologic Category: Radiological/Contrast Media (Nonionic, Low Osmolality)
Dosage Form and Strengths: 287 mg/mL (10 mL) solution in a vial for injection
Indications: Roniscan is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity within the thoracic (noncardiac), abdominal, pelvic cavities, and retroperitoneal space (Body imaging) and also lesions with abnormal vascularity in the brain, spine, and associated tissues (CNS imaging).
کیفیت دارو
وزارت بهداشت
کافی و مناسب
سلامت بیماران
Remdesivir has finally received FDA approval from the US Food and Drug Administration.
People with diabetes are at risk for more serious complications from Covid-19, but the risk of infection is reduced by maintaining proper blood sugar levels and taking precautions.
Remdesivir has finally received FDA approval from the US Food and Drug Administration.
People with diabetes are at risk for more serious complications from Covid-19, but the risk of infection is reduced by maintaining proper blood sugar levels and taking precautions.